Peer Review History
| Original SubmissionOctober 1, 2021 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-21-31678A Comparison of Attitudes and Knowledge of pre-exposure prophylaxis (PrEP) between hospital and Key Population Led Health Service providers: Lessons for Thailand’s Universal Health Coverage implementationPLOS ONE Dear Dr. Rayanakorn, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Benjamin R. Bavinton Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please ensure that you have specified (1) whether consent was informed, (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee and (3) If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Overall, research method is somewhat questionable and can easily introduce the bias to interpret the study and make the whole study not valid. The number of participants were small and skewed towards people from KPLHS. I would suggest authors to describe the temporal trends of the PrEP uptake in Thailand to see a clearer picture and compare whether KPLHS in other countries do provide PrEP in the same manner as in Thailand. Page 6, line 131. How many missing values were excluded from the analysis? Did that create a bias? Page 6, line 136-138 and Page 18 Line 343-346. Please explain why more people per KPLHS responded more than per hospital? Is there any incentive to answer the questionnaire? Why did the research team choose these 4 KPLHS? Do they provide more PrEP services than the hospitals? Page 7, line 148. Please explain what is traditional physician and provide more detail about the right to prescribe PrEP by traditional physician in Thailand. Page 11, Line 171. Unclear if the title is completed. Page 13, Line 225. I would suggest to add these answers to the background or discussion. What kind of training and how often the training occur currently? Any particular certificates needed prior to be PrEP providers? Reviewer #2: Summary This study aimed to determine the KAP of PrEP service providers from hospitals and HPLHS to aid in planning for the roll-out of PrEP amid the UHC. The authors did a cross-sectional online survey among PrEP providers in KPLHS and hospitals to assess their knowledge and attitudes. Although qualitative data may have been collected through comments (part 3), data and analysis have been done mostly quantitatively. They used descriptive statistics to summarize the data and independent t-test to compare means. Their results showed significant differences between the characteristics, knowledge and attitude in PrEP provision, and identified needed support between providers of KPLHS and the hospitals. This study not only provided insights on the key role of the KPLHS but also the role of UHC in provision of PrEP. Largely, I believe that this is a very well-written and strong manuscript. The analysis on UHC, if further strengthened, is very timely and could help other countries shape their HIV service delivery amid transition towards the UHC. I do, however, have several comments for your consideration to further improve the manuscript for publication. Introduction In general: Kindly consider providing context on the state of the UHC implementation in Thailand (particularly, whether PrEP is considered a public-level intervention that the cost of which will be covered by the government). Could also consider clarifying describing the role of KPLHS in the primary care setting amid the UHC - i.e., does it receive funding from the government, does it heavily depend on donor funding? Lastly, could consider providing information whether PrEP is accessible for free or at-cost. Kindly consider changing from "AIDs" to "AIDS" Page 3, line 58-59 - Could the authors clarify if this is AIDS epidemic, endemic, or pandemic? Methods Page 4, line 93: There was no adequate description of the study settings, especially how KPLHS fit into the larger picture of UHC implementation in Thailand. Page 4, line 98 - Bisexual is not gender but a sexual orientation. Gender indentity can be cis-gender, transgender, or non-binary. Sexual orientation includes homosexual, bisexual, and etc. Moreover, TGW can self-identify as homosexual, bisexual, and etc. Page 5, line 101 - NHSO should be spelled out. Page 5, line 105 - when we say "in comments", do the authors mean qualitatively? This could be clarified further. Moreover, it could be clarified whether how the "first three" were collected - were these based on the first three that come into the participants' minds or based on necessity? Page 5, line 113 - The authors could consider removing the definition of QR code for brevity. Page 5, line 113-121 - Sampling technique was not discussed. The authors could further explain the technique and calculations, if necessary. Inclusion and exclusion criteria for participants were not explicitly stated. Page 7, line 148 - Can the authors clarify what a "traditional physician" is? Results Page 7, Table 1 - Can the authors clarify the purpose of the variable "current gender"? I am aware that it is challenging to classify participants based on SOGIE but it is recommended that the decision on classification would depend on the research question. As mentioned in the earlier comment, sexual orientation and gender identity are 2 different concepts that TGW can identify themselves as lesbians or gay, as well. Hence, I would recommend revisiting this variable and putting the research question at heart. If it was only intended to illustrate that the KPLHS services were mostly facilitated by KP (cisgender MSM and TGW), then mentioning "KP group", with classifications such as (1) cis-MSM, (2) TGW, and (3) heterosexual male and female, would I think be suffice. See table in https://doi.org/10.1016/S2352-3018(18)30148-6 as an example. Page 7, line 150-152 - The way the authors explained the context at KPLHS was commendable. I would suggest putting this in the main text rather than a table caption. Discussion Page 15-16, lines 263-279 - I commend the authors providing insight in the KPLHS. It is indeed key to addressing the disproportionate increase in HIV incidence among KP in Thailand. However, it could also be interesting if there were insights on the hospitals as PrEP providers and the integration of the KPLHS in the primary care setting amid the UHC. Discussions like these have to be started, especially as many low- and middle-income countries are transitioning towards the UHC and that donor funding in HIV is decreasing. Page 16, lines 281-296 - Pretty good insight on the attitudes of providers. Do the authors likewise think that their attitudes might be influenced by their clientèle profile? It would be interesting to note whether hypothetically most of the MSM and TGW are being provided PrEP in the KPLHS, whereas sex workers are mostly accessing in the hospital. Is there such data in Thailand that could provide insights on this? Page 16, lines 292-293 - Negative attitude on effectiveness of PrEP on TGW among hospital providers was higher than in the KPLHS. I really commend the authors for emphasizing this as based on Figure 2, it seems that there was a disproportionately higher negative attitude among hospital providers specifically to this. The authors could also reconsider hospitals being sensitized or trained on transgender-related health issues and not only rely on KPLHS for service delivery. Conversely, this could open discussions for the attitudes of TGW among hospital providers and their preference for KPLHS. Nonetheless, I think there is always benefit in investigating this point further. Page 17, lines 307-316 - Great insights! Page 18, lines 338-340 - More context is needed here. What is the role of UHC in KPLHS? Does UHC only provides free services in hospitals and not in KPLHS? Page 18-19, lines 341-357 - The authors did a good job providing a comprehensive list of limitations. They could consider also providing their insights on: (1) limitations on the coding of qualitative into quantitative data as I assumed it precluded more robust means of comparing proportions like chi-square; (2) information bias, if applicable Page 18, lines 344-350 - Could this also be self-selection bias? It is a very common form of bias among volunteer samples. Apart from the response rates, were there any responses that were terminated in between responding, leading to attrition of respondents and high missing values? Conclusions In general: Conclusions are supported by the findings. Page 19, lines 359-367 - I would recommend the authors to also provide their insights (also applies in the discussion part) on how KPLHS fits in the larger picture of UHC. From reading this manuscript, the systems wherein the KPLHS and hospitals operate seem to be very separate. The spirit of UHC is towards integrating service delivery. Moreover, a big issue in KPLHS is sustainability especially if donor funding would decrease. Is UHC key to sustainability of KPLHS? I would be interested to hear the insights of our authors on this point. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
A Comparison of Attitudes and Knowledge of pre-exposure prophylaxis (PrEP) between hospital and Key Population Led Health Service providers: Lessons for Thailand’s Universal Health Coverage implementation PONE-D-21-31678R1 Dear Dr. Rayanakorn, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Benjamin R. Bavinton Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for responding to comments and editing the manuscript accordingly. I have no further comments. Reviewer #2: Thank you for responding to all the comments. I think all the responses were comprehensive and the current manuscript reflects significant changes. While I believe that the current form is worthy of publication, I would encourage the authors to be more explicit with the sampling technique. I do acknowledge that no power calculations have been done, but it is likely that a non-probabilistic sampling has been used (i.e., maybe convenience sampling). Various reporting guidelines recommend stating the sampling technique utilized. Nonetheless, I have no further suggestions. Good luck to the authors! ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Rapeephan Rattanawongnara Maude Reviewer #2: Yes: Patrick Eustaquio |
| Formally Accepted |
|
PONE-D-21-31678R1 A Comparison of Attitudes and Knowledge of pre-exposure prophylaxis (PrEP) between hospital and Key Population Led Health Service providers: Lessons for Thailand’s Universal Health Coverage implementation Dear Dr. Rayanakorn: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Benjamin R. Bavinton Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .